Doptelet and Doptelet Sprinkle (avatrombopag) are prescription medications approved by the U.S. Food and Drug Administration (FDA) to treat low platelet counts in children ages 1 and older with persistent or chronic immune thrombocytopenia (ITP). Platelets are blood cells that help stop bleeding. Avatrombopag is also used to treat adults with chronic ITP for whom a previous treatment did not work well enough.

Nplate (romiplostim) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat low platelet counts in adults and children ages 1 and older with immune thrombocytopenia (ITP).

Privigen (immune globulin intravenous [human]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat low platelet counts in people aged 15 years and older with chronic immune thrombocytopenic purpura (ITP).

Promacta (eltrombopag) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat low platelet counts in children ages 1 year and older with persistent or chronic immune thrombocytopenia (ITP).

Tavalisse (fostamatinib disodium hexahydrate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic immune thrombocytopenia (ITP).

Wayrilz (rilzabrutinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with persistent or chronic immune thrombocytopenia (ITP).

WinRho SDF (Rho[D] immune globulin intravenous [human]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help raise platelet counts in certain children and adults with immune thrombocytopenic purpura (ITP).